San Francisco telehealth company Hims & Hers saw its stock plunge more than 30% earlier this week after a partnership with ...

Discover why Hims & Hers is leading the telehealth market with strong growth, a loyal user base, and expansion into new health segments.

Hims & Hers Health, Inc. sees 38% YoY subscriber growth, driven by 70% choosing personalized treatments. Click for my updated ...

Explore Hims & Hers Health stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for HIMS.

Hims aims to provide accessible health care, without insurance, for an affordable price. There is no membership fee for Hims, you're only paying for your care, which can start as low as $1 per day.

Shares of Hims & Hers soared $4.21, or 29%, to $18.79 in Monday afternoon trading. GLP-1 drugs, which stands for glucagon-like peptide 1 agonists, help people feel fuller and less hungry, aiding ...

HIMS stock sank 22% after that announcement in February, reported CNBC at the time. It’s understandable, then, why HIMS shares are surging so much in trading today after the company announced ...

But Hims & Hers Health Inc. - the online telehealth platform best known for selling hair-loss treatments, Viagra and Cialis - said customers are still piling in.

Hims & Hers’ stock price has swung wildly this year. The telehealth company’s public feud with drugmaker Novo Nordisk knocked off a nearly a third of its valuation on Monday.

Hims & Hers' stock price has swung wildly this year. The telehealth company's public feud with drugmaker Novo Nordisk knocked off a nearly a third of its valuation on Monday. On Friday, Hims ...